Related Experiment Videos
Kaposi's sarcoma in patients with membranous nephropathy
Weihua Liu1, Feiyue Lin2, Xin Chen3
1Department of Nephrology, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China.
Abstract:
Although the relationship between Kaposi's sarcoma (KS) and renal transplant has been well described, there are rare cases of KS concurrent with membranous glomerulonephritis or other glomerular diseases. In this report, a patient with membranous glomerulonephritis that accepted long-term prednisolone and cyclosporine immunosuppressive therapy developed skin KS. Withdrawal of immunosuppressive treatment resulted in the disappearance of KS.
Insights
Kaposi's sarcoma (KS), a rare skin cancer, can develop in kidney transplant patients undergoing immunosuppression. This case shows that stopping immunosuppressive drugs may lead to KS regression.
Area of Science:
- Nephrology
- Oncology
- Immunology
Background:
- Kaposi's sarcoma (KS) is an opportunistic malignancy often associated with immunosuppression after organ transplantation.
- While KS and renal transplantation are linked, concurrent cases with glomerular diseases like membranous glomerulonephritis are exceptionally rare.
Observation:
- A patient with membranous glomerulonephritis received long-term immunosuppressive therapy including prednisolone and cyclosporine.
- The patient subsequently developed cutaneous Kaposi's sarcoma.
Findings:
- Withdrawal of the immunosuppressive regimen led to the complete resolution of the Kaposi's sarcoma.
- This suggests a direct link between immunosuppression intensity and KS development in this context.
Implications:
- Careful monitoring for opportunistic infections, including KS, is crucial in immunosuppressed renal transplant recipients.
- Immunosuppression management may play a role in preventing or treating KS in these vulnerable patients.
- Further research into the specific mechanisms linking immunosuppression, glomerular disease, and KS is warranted.